Global Antiemetics Drugs Market Size To Exceed USD 14.45 Billion By 2035 | CAGR Of 5.70%
Category: HealthcareGlobal Antiemetics Drugs Market Size To Exceed USD 14.45 Billion By 2035
According to a Research Report Published by Spherical Insights & Consulting, The Global Antiemetics Drugs Market Size is Expected to Grow from USD 7.85 Billion in 2024 to USD 14.45 Billion by 2035, at a CAGR of 5.70% during the Forecast Period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 245 pages with 120 Market data tables and figures & charts from the report on the "Global Antiemetics Drugs Market Size, Share, and COVID-19 Impact Analysis, Drug Type (Serotonin-Receptor Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, and Others), By Application (Chemotherapy, Gastroenteritis, Post Operative Surgery, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/antiemetics-drugs-market
The Global Market Size for Antiemetics Drugs is the industry focused on producing, promoting, and distributing medications meant to prevent or treat nausea and vomiting. Chemotherapy-induced nausea, motion sickness, gastroenteritis, and post-operative nausea are all commonly treated with these drugs. The market for antiemetics drugs is primarily focused on the development, production, and distribution of medications meant to prevent and treat nausea and vomiting. Motion sickness, gastrointestinal problems, post-operative rehabilitation, and chemotherapy-induced nausea are among the many conditions for which these drugs are commonly used. The market for antiemetics drugs is expanding significantly due to an increase in nausea and vomiting brought on by several illnesses, including cancer, pregnancy, and the healing process following surgery. The need for efficient antiemetic medications is rising as a result of increased knowledge of healthcare and patient outcomes. With the aging of the population and changing lifestyles, more people will probably develop health issues that call for antiemetic treatments, which will increase demand and propel the market for antiemetics drugs towards growth. The market for antiemetics drugs is expanding significantly as a result of the increased prevalence of several illnesses linked to nausea and vomiting. However, regulatory barriers and competition from well-established medications are the two challenges facing the global antiemetics drugs market.
The serotonin-receptor antagonists segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the drug type, the antiemetics drugs market is divided into serotonin-receptor antagonists, anticholinergics, dopamine receptor antagonists, neurokinin receptor antagonists, and others. Among these, the serotonin-receptor antagonists segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The segment on serotonin-receptor antagonists contains medications such as Granisetron (Kytril), Dolasetron (Anzemet), and Ondansetron (Zofran).
The chemotherapy segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the antiemetics drugs market is divided into chemotherapy, gastroenteritis, post operative surgery, and others. Among these, the chemotherapy segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The growing number of new products in this market and the growing usage of antiemetics to treat chemotherapy-related nausea and vomiting are the reasons for the chemotherapy segment.
North America is expected to hold the majority share of the global antiemetics drugs market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global antiemetics drugs market during the forecast period. Growth in the North America area is anticipated to be fueled by an increase in antiemetic drug approvals. North America's dominant market share highlights the region's importance due to its sophisticated healthcare system and high level of disposable income.
Asia Pacific is anticipated to grow at the fastest pace in the global antiemetics drugs market during the forecast period. The need for antiemetic medications rises as a result of policies that support early cancer identification, diagnosis, and treatment as part of overall cancer care plans in Asia Pacific region.
Major vendors in the global antiemetics drugs market are GSK plc, Cipla Limited, Novartis AG,Pfizer Inc., Viatris Inc., Merck & Co., Inc., Johnson & Johnson, Astellas Pharma Inc., Baxter International Inc., Glenmark Pharmaceuticals Limited, Teva Pharmaceutical Industries Limited, Eagle Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC, Torrent Pharmaceuticals Limited, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In January 2023, in an exclusive licensing arrangement with the Swiss biopharma group Helsinn, Glenmark Pharmaceuticals Ltd. launched the intravenous injection formulation AKYNZEO I.V. The goal of AKYNZEO I.V. is to stop chemotherapy-induced nausea and vomiting (CINV). It comes as an IV injection that is ready to dilute and contains a fixed dose of fosnetupitant (235 mg) and palonosetron (0.25 mg).
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the antiemetics drugs market based on the below-mentioned segments:
Global Antiemetics Drugs Market, By Drug Type
- Serotonin-receptor Antagonists
- Anticholinergics
- Dopamine Receptor Antagonists
- Neurokinin Receptor Antagonists
- Others
Global Antiemetics Drugs Market, By Application
- Chemotherapy
- Gastroenteritis
- Post Operative Surgery
- Others
Global Antiemetics Drugs Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?